ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, N.
Right arrow Articles by Bailey, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, N.
Right arrow Articles by Bailey, L. L.

Ann Thorac Surg 1994;57:289-292
© 1994 The Society of Thoracic Surgeons


Articles

Pericardioperitoneal shunt: An alternative treatment for malignant pericardial effusion

Nan Wang, MD*, J.Randall Feikes, MD, Thomas Mogensen, BS, Edwin E. Vyhmeister, MD, Leonard L. Bailey, MD

Division of Cardiothoracic Surgery, Department of Surgery, Loma Linda University Medical Center, Loma Linda, California, USA

* Address reprint requests to Dr Wang, Department of Surgery, Lama Linda University Medical Center, 11234 Anderson St, Loma Linda, CA 92354.


    Abstract
 Top
 Abstract
 Footnotes
 References
 
The treatment of 37 consecutive cases of symptomatic malignant pericardial effusion over a period of 13 years was retrospectively analyzed. The most common diagnoses were lung cancer (59%) and breast cancer (11%). In the most recent 4 patients, the Denver pleuroperitoneal shunt was used to drain the pericardial effusion into the peritoneal cavity. In each case, the procedure was performed under local anesthesia, and the patient was discharged 2 to 4 days later without complications. Three of the patients subsequently died of the disease process without evidence of cardiac failure or tamponade during 6-month follow-up. The more traditionl events of pericardial drainage, the subxiphoid approach (14 patients) and the anterior thotacotomy approach (19 patients), were associated with higher postoperative morbidity (21% and 53%, respectively) and mortality (7% and 42%, respectively). Because of the small number of patients treated by pericardioperitoneal shunting, a significant difference was demonstrated only in the length of hospital stay (shunt, 2.8 ± 0.5 days; subxiphoid, 11.2 ± 4.6 days; thoracotomy, 14.9 ± 6.1 days). Median survivals were essentially the same (shunt, 3.5 months; subxiphoid, 2.7 months; thoracotomy, 1.2 months). It is apparent that the pericardioperitoneal shunt, although a much simpler procedure, can accomplish similar palliation effectively in the treatment of malignant pericardial effusion.


    Footnotes
 Top
 Abstract
 Footnotes
 References
 
{star} Presented at the Poster Session of the Twenty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Anlonio. TX. Jan 25–27, 1993.


    References
 Top
 Abstract
 Footnotes
 References
 

  1. Larrey DJ. New surgical procedure to open the pericardium in case of fluid in its cavity Clin Chir 1829;2:303-337.
  2. Park SP, Rentschler R, Wilbur D. Surgical management of pericardial effusion in patients with malignancies: comparison of subxiphoid window versus pericardiectomy Cancer 1991;67:76-80.[Medline]
  3. Sugimolo JT, Little AG, Ferguson MK, et al. Pericardial window: mechanisms of efficacy Ann Thorac Surg 1990;50:442-445.[Abstract/Free Full Text]
  4. Smith FE, Lane M, Hudgins P. Conservative management of pericardial effusion Cancer 1974;33:47-57.[Medline]
  5. Hankins JR, Satlerfield JR, Aisner J, Wiernik PH, McLaughlin JS. Pericardial window for malignant pericardial effusion Ann Thprac Surg 1980;30:465-471.
  6. Snow N, Lucas A. Subxiphoid pericardiotamy: a safe, accurate, diagnostic and therapeutic approach to pericardial and intrapericardial disease Am Surg 1983;49:249-253.[Medline]
  7. Larrieu AJ, Ghosh SC, Ablaza SG, Grana VP. Favorable results with the subxiphoid pericardial window technique J Thorac Cardiovasc Surg 1986;91:639-640.[Medline]
  8. Santos GH, Frater RWM. The subxiphoid approach in the treatment of pericardial effusion Ann Thorac Surg 1977;23:467-470.[Abstract/Free Full Text]
  9. Piehler JM, Pluth JR, Schaff HV, Danielson GK, Orszulak TA, Puga FJ. Surgical management of effusive pericardial disease Influence of extent of pericardial resection on clinical course J Thorac Cardiovasc Surg 1985;90:506-516.[Abstract]
  10. Spodick DH. Pericardial windows are suboptimal [Letter] Am J Cardiol 1983;51:607.[Medline]
  11. Little AG, Kadowaki MH, Ferguson MK, Staszek VM, Skinner DB. Pleuro-peritoneal shunting Alternative therapy for pleural effusions Ann Surg 1988;208:443-450.[Medline]
  12. Krikorian JG, Hancock EW. Pericardiocentesis Am J Med 1978;65:808-814.[Medline]
  13. Shepherd FA, Ginsberg JS, Evans WK, Scott JG, Oleksiuk P. Tetracycline sclerosis in the management of malignant pericardial effusion J Clin Oncol 1985;3:1678-1682.[Abstract/Free Full Text]
  14. Martini N, Freiman A, Watson R, Hilaris B. Intrapericardial instillation of radioactive chromic phosphate in malignant pericardial effusion AJR 1977;128:639-641.[Abstract]
  15. Cham WC, Freeman AH, Carstens PHB. Radiation therapy of cardiac and pericardial métastases Ther Radiol 1975;114:701.
  16. Dean RH, Killen DA, Daniel Jr RA, Collins HA. Experience with pericardiectomy Ann Thorac Surg 1973;15:378-385.[Abstract/Free Full Text]
  17. Little AG, Kremser PC, Wade JL, Levett JM, DeMeester TR, Skinner DB. Operation for diagnosis and treatment of pericardial effusions Surgery 1984;96:738-744.[Medline]
  18. Griffin S, Fountain W. Pericardio-peritoneal shunt for malignant pericardial effusion [Letter] J Thorac Cardiovasc Surg 1989;98:1153-1154.[Medline]
  19. Molnar TF, Jeyasingham K. Pericardioperitoneal shunt for persistent pericardial effusions: a new drainage procedure Ann Thorac Surg 1992;54:569-570.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
L. N. Girardi, R. J. Ginsberg, and M. E. Burt
Pericardiocentesis and Intrapericardial Sclerosis: Effective Therapy for Malignant Pericardial Effusions
Ann. Thorac. Surg., November 1, 1997; 64(5): 1422 - 1427.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, N.
Right arrow Articles by Bailey, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, N.
Right arrow Articles by Bailey, L. L.